Brand tirzepatide
Sold by Ro · every brand tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
First month
$338
Every month after
$448
| Medication · Zepbound KwikPen (brand tirzepatide) | $299 |
|---|---|
| Required membership · First month 39 | $149 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Zepbound KwikPen (brand tirzepatide) “$299/mo for 2.5 mg dose” | Per month$299 | Charged today$299 |
We earn nothing from this link. Ro has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Term added: Zepbound KwikPen (brand tirzepatide)
- August 31, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed as of August 31, 2026 |
|---|---|
| States | All 50 states |
| Prescriber | Both |
| Cancellation | “Unfortunately we cannot issue refunds or accept returns of prescription products for reuse or resale, and all sales are final.” |
| Membership | Required. $149 per month. “Ro's pricing page states that the cost of medication is not included in the membership fee and describes the structure as two separate charges.” |
| Consult fee | Not disclosed as of August 31, 2026 |
Recorded from ro.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.